The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Nmethyl-5-(2-oxo-2-(phenylamino)ethoxy)-2-((tetrahydro-2Hpyran-4-yl)oxy)benzamide) ID: ALA3775323
PubChem CID: 105539871
Max Phase: Preclinical
Molecular Formula: C21H24N2O5
Molecular Weight: 384.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1cc(OCC(=O)Nc2ccccc2)ccc1OC1CCOCC1
Standard InChI: InChI=1S/C21H24N2O5/c1-22-21(25)18-13-17(7-8-19(18)28-16-9-11-26-12-10-16)27-14-20(24)23-15-5-3-2-4-6-15/h2-8,13,16H,9-12,14H2,1H3,(H,22,25)(H,23,24)
Standard InChI Key: OLSMYKUQDJESEU-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 1.4978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9336 -3.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -7.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4884 -8.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7875 -7.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7875 -6.0110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4885 -5.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0351 3.6026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3064 4.9494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2007 1.4910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4972 0.7365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4920 -0.7635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1904 -1.5090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8939 -0.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
2 8 1 0
7 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
8 23 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.43Molecular Weight (Monoisotopic): 384.1685AlogP: 2.62#Rotatable Bonds: 7Polar Surface Area: 85.89Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.54CX Basic pKa: ┄CX LogP: 1.61CX LogD: 1.61Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.77Np Likeness Score: -1.15
References 1. Chaikuad A, Lang S, Brennan PE, Temperini C, Fedorov O, Hollander J, Nachane R, Abell C, Müller S, Siegal G, Knapp S.. (2016) Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain., 59 (4): [PMID:26731131 ] [10.1021/acs.jmedchem.5b01719 ] 2. Humphreys PG, Bamborough P, Chung CW, Craggs PD, Gordon L, Grandi P, Hayhow TG, Hussain J, Jones KL, Lindon M, Michon AM, Renaux JF, Suckling CJ, Tough DF, Prinjha RK.. (2017) Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe., 60 (2): [PMID:28002667 ] [10.1021/acs.jmedchem.6b01566 ]